Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine established the Sylvester Pancreatic Cancer Research Institute. The center will support research, increase collaborations between scientists and clinicians, and provide more treatment and clinical trial opportunities for patients.
In a phase II clinical trial, a research team led by Nilofer Azad, professor of oncology and co-leader of the Kimmel Cancer Center’s Cancer Genetics and Epigenetics Program, and Marina Baretti, the Jiasheng Chair in Hepato-Biliary Cancer at the Kimmel Cancer Center, tested the safety and efficacy of the combination of two drugs: an immunotherapy, nivolumab, and an epigenetic drug, entinostat—a histone deacetylase inhibitor.
